Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 33.88 |
| Open | 33.32 |
| Bid | 33.00 x 800 |
| Ask | 36.30 x 2900 |
| Day's range | 33.01 - 35.11 |
| 52-week range | 32.96 - 107.69 |
| Volume | |
| Avg. volume | 239,291 |
| Market cap | 850.09M |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Recently Published Data Confirm DecisionDx®-SCC as a Significant and Independent Risk-Stratification Tool in Patients with Squamous Cell Carcinoma and One or More Risk Factors
FRIENDSWOOD, Texas, January 13, 2022--Castle announced the publication of clinical performance study data related to DecisionDx®-SCC in Future Oncology.
- Business Wire
Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UMSeq for Patients with Uveal Melanoma
FRIENDSWOOD, Texas, January 12, 2022--Castle announced the publication of a study in Ocular Oncology and Pathology related to the Company's DecisionDx®-UMSeq 7-gene DNA sequencing panel.
- Business Wire
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2021 Results
FRIENDSWOOD, Texas, January 10, 2022--Castle today announced certain unaudited preliminary performance results for the fourth quarter and full-year 2021.
© 2022 Yahoo. All rights reserved.
